Ainos, Inc. (AIMD)
| Market Cap | 7.09M -61.5% |
| Revenue (ttm) | 13,600 -87.7% |
| Net Income | -14.45M |
| EPS | -2.49 |
| Shares Out | 7.38M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 68,987 |
| Open | 0.9300 |
| Previous Close | 0.9600 |
| Day's Range | 0.8702 - 1.0300 |
| 52-Week Range | 0.8702 - 4.4400 |
| Beta | 2.48 |
| Analysts | n/a |
| Price Target | n/a |
| Est. Earnings | Nov 12, 2026 |
About AIMD
Ainos, Inc., a dual-platform company, focusing artificial intelligence–based smelltech technologies and immune therapeutics. It offers AI Nose, an AI-based electronic olfaction system, which uses a smell language model to digitize scent into Smell IDs and turning into machine-readable data. The company provides its platforms for semiconductor manufacturing, robotics, and smart manufacturing industries; as well as senior care and women’s health sectors. In addition, it develops VELDONA, a low-dose oral interferon platform for human and animal he... [Read more]
Financial Performance
In 2025, Ainos's revenue was $124,157, an increase of 498.95% compared to the previous year's $20,729. Losses were -$14.77 million, -0.62% less than in 2024.
Financial StatementsNews
Ainos completes VELDONA technology transfer
Ainos (AIMD) has completed the required data delivery and technology transfer under its VELDONA license agreement, triggering a $600,000 initial license payment. The licensing partner confirmed comple...
Ainos Completes VELDONA Technology Transfer, Triggering $600,000 License Payment
Partner's Written Confirmation Fulfills Payment Conditions; Initial License Fee Payable Within 15 Business Days HOUSTON, TX / ACCESS Newswire / September 30, 2026 / Ainos, Inc. (NASDAQ:AIMD)(NASDAQ:AI...
Ainos completes delivery of 1,400 AI nose systems to ASE
Ainos (AIMD) has completed delivery of all 1,400 AI Nose systems to ASE Technology Holding under the announced $2.1M, three-year agreement. The completed delivery marks a major commercial milestone fo...
Ainos Completes Delivery of 1,400 AI Nose Systems to ASE Under $2.1 Million, Three-Year Contract
Preparations underway for a larger-scale second-phase deployment specified in the existing MOU, building on first-phase deployment experience Advanced packaging deployment marks a major step for Ainos...
Ainos details partner-funded VELDONA development opportunities
Ainos (AIMD) detailed the financial and strategic benefits of the VELDONA License Agreement announced on September 24. Ainos expects to complete the agreed contractual delivery shortly, with an initia...
Ainos Details Partner-Funded VELDONA Development and Revenue Opportunities, Reinforcing Focus on Chemical Intelligence
Initial license payment tied to near-term contractual delivery; additional payment opportunities may arise during development, before drug approval Partner assumes assigned clinical and regulatory fun...
Ainos, BioPhoenix sign VELDONA license agreement
Ainos (AIMD) entered into a VELDONA License Agreement with BioPhoenix, establishing a collaboration framework with a potential aggregate value of $10M. The framework comprises an initial license fee, ...
Ainos and BioPhoenix Sign VELDONA License Agreement, Establishing a Potential $10 Million Collaboration Framework
Partner-funded development marks an important milestone for VELDONA, with BioPhoenix funding and advancing clinical and regulatory development for two initial indications Development funding is additi...
VASRO Research Highlights Ainos' New Order, Semiconductor Commercial Momentum and 1 Billion+ Chemical Dataset
Report points to front-end semiconductor orders, a $2.1 million back-end program and continued dataset expansion as key indicators of Ainos' growing commercial scale HOUSTON, TX / ACCESS Newswire / Se...
Ainos advances AI Nose into deployment in semiconductor manufacturing
Ainos (AIMD) announced that its second-generation AI Nose platform is advancing into commercial deployment in front-end semiconductor manufacturing, building on validation activities initiated earlier...
Ainos Advances AI Nose into Commercial Deployment in Front-End Semiconductor Manufacturing
Initial commercial orders mark progress toward broader commercial adoption and support revenue-generation opportunities beginning in 2H 2026 Proprietary real-world chemical dataset surpasses 1 billion...
Ainos secures three Japanese robotics patents
Ainos (AIMD) announced that it has secured three new Japanese patents covering AI Nose technologies and their integration with robotic systems. The newly granted patents cover gas exchange, rapid chem...
Ainos Secures Three Japanese Robotics Patents, Advancing Chemical Perception for the Physical AI Era
New patents cover electronic nose integration with robotics, expanding Ainos' portfolio of 124 patent assets worldwide across chips, sensing architectures, chemical molecules and real-world applicatio...
Ainos announces global launch of Atmosphere Engine
Ainos (AIMD) announced the global launch of Atmosphere Engine, a new platform that extends the Company’s capabilities in AI-powered environmental sensing, Chemical Intelligence and smart manufacturing...
Ainos Launches Atmosphere Engine, Extending Physical AI from Environmental Sensing to Active Environmental Management
High-efficiency, on-site nitrogen generation is designed to protect high-value AI infrastructure, reduce oxidation and environmental degradation, and bring greater flexibility and resilience to semico...
Ainos announces next generation of AI Nose platform
Ainos (AIMD) announced the next generation of its AI Nose platform, featuring comprehensive upgrades across software, firmware, edge computing and hardware reliability. The second-generation AI Nose i...
Ainos Unveils Next-Generation AI Nose, Advancing the Infrastructure for Chemical Intelligence
Second-generation platform combines upgraded software, firmware, Edge AI and industrial-grade hardware to support reliable 24/7 real-world deployment More than 878 million real-world smell data record...
Ainos announces AI Nose platform surpassed 878M small, chemical data points
Ainos (AIMD) announced that its AI Nose platform has surpassed 878M real-world smell and chemical data points, primarily generated from semiconductor manufacturing and real-world operating environment...
Ainos Surpasses 878 Million Real-World Data Points, Up 43% in 23 Days as 1,400-System AI Nose Semiconductor Deployment Advances
Dataset expands by approximately 265 million data points since July 21 as continued AI Nose system deployment across semiconductor manufacturing environments accelerates Ainos' Real-World Data Flywhee...
Ainos to Showcase Environmental Intelligence for Physical AI at SEMICON Taiwan 2026
AI Nose and Atmosphere Engine bring a new layer of environmental perception to intelligent machines HOUSTON, TX / ACCESS Newswire / August 12, 2026 / Ainos, Inc. (NASDAQ:AIMD)(NASDAQ:AIMDW) ("Ainos" o...
VASRO Research Highlights Ainos' Progress in Scaling Smell AI Commercialization and Compounding Its Smell ID Dataset
HOUSTON, TX / ACCESS Newswire / August 10, 2026 / Ainos, Inc. (NASDAQ:AIMD)(NASDAQ:AIMDW) ("Ainos" or the "Company") today announced VASRO GmbH has published a new report discussing Ainos' progress in...
Zacks Small-Cap Research Covers Ainos' AI Nose Platform and Expansion of Smell AI Applications
HOUSTON, TX / ACCESS Newswire / August 6, 2026 / Ainos, Inc. (NASDAQ:AIMD, AIMDW) ("Ainos" or the "Company") today announced that Zacks Small-Cap Research ("Zacks SCR") has published a research report...
Ainos Reports Second Quarter 2026 Results and Highlights Continued AI Nose Execution Across Industrial, Healthcare Infrastructure and Robotics Markets
HOUSTON, TX / ACCESS Newswire / August 3, 2026 / Ainos, Inc. (NASDAQ:AIMD)(NASDAQ:AIMDW) ("Ainos" or the "Company") today announced results for the second quarter ended June 30, 2026, and provided a b...
Ainos Quarterly report: Q2 2026
Ainos has published its Q2 2026 quarterly earnings report on August 3, 2026.
Ainos Earnings release: Q2 2026
Ainos released its Q2 2026 earnings on August 3, 2026, summarizing the period's financial results.